G

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Senior Medical Director - Clinical Development, MD

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • MD or DO with at least 6 years of clinical, scientific, and/or drug development experience, including substantial experience in biopharmaceutical clinical development.
  • Willingness to travel up to 25%.

Responsibilities

  • Lead the clinical development strategy for one or more oncology programs, providing scientific and medical leadership from IND-enabling activities through proof-of-concept and early development milestones.
  • Provide clinical oversight and medical monitoring across one or more clinical studies, ensuring participant safety, data integrity, and high-quality execution.
  • Lead cross-functional teams in the design, implementation, and execution of clinical development plans and clinical studies.
  • Author and review protocols, investigator brochures, clinical study reports, regulatory documents, and other key clinical development deliverables.
  • Provide strategic leadership for regulatory interactions and submissions, including INDs, health authority meetings, and regulatory responses, as applicable.
  • Collaborate with Research, Translational Sciences, Clinical Operations, Safety, Regulatory Affairs, and CMC teams to advance development programs and achieve key milestones.
  • Build and maintain relationships with investigators, key opinion leaders, scientific advisors, and other external stakeholders.
  • Present clinical data and development strategies to governance committees, health authorities, scientific conferences, and investigator meetings; lead or contribute to scientific publications and presentations.
  • Mentor junior physicians and contribute to portfolio strategy, business development evaluations, and external innovation assessments, as applicable.
  • Create inclusion by modeling inclusion and embedding the value of diversity in how teams are managed.
  • Develop talent by understanding employees’ skills, experience, aspirations, and potential, coaching them on current performance and future potential, and ensuring they receive feedback and insight to grow and develop.
  • Empower teams by aligning goals, purpose, and organizational objectives, holding teams accountable, removing barriers, and connecting teams to the broader organization.

Desired Qualifications

  • Board certification in Hematology/Oncology or a related specialty.
  • Significant experience leading oncology drug development programs with responsibility for clinical strategy and execution.
  • Demonstrated experience leading first-in-human, proof-of-concept, and registrational development programs.
  • Cell therapy experience, including autologous, allogeneic, and/or in vivo cellular therapy platforms.
  • Experience leading interactions with global health authorities and supporting major regulatory submissions.
  • Demonstrated ability to influence cross-functional teams and drive decision-making in a matrix environment.
  • Track record of scientific leadership through publications, presentations, advisory boards, and engagement with external experts and key opinion leaders.
  • Experience mentoring and developing physicians, scientists, and cross-functional team members.
  • Strategic thinking that balances scientific rigor, operational feasibility, regulatory requirements, and business objectives.
  • Experience evaluating external innovation, licensing opportunities, partnerships, or business development transactions.
  • Ability to thrive in a dynamic and evolving environment while managing competing priorities with minimal direction.

About the Company

Gilead Sciences

Makes medicines for HIV, liver disease and cancer

Gilead Sciences is a biopharmaceutical company that discovers, develops and sells medicines for HIV, viral hepatitis and other liver diseases, cancer and inflammatory conditions. Its HIV business covers both treatment, led by the once-daily pill Biktarvy, and prevention, including Descovy and Yeztugo, a lenacapavir injection given twice a year. In cancer, its Kite unit makes CAR T-cell therapies from patients' own immune cells, and Trodelvy is an antibody-drug conjugate for breast cancer. Gilead earns revenue by selling its drugs to wholesalers, specialty pharmacies, hospitals and governments worldwide after regulatory approval. The company was founded in 1987 and is headquartered in Foster City, California.

Company size
10,001+
Company stage
IPO
Headquarters
Foster City, CA
Founded
1987

Recently Posted Jobs

Explore more opportunities at Gilead Sciences

See more jobs